News and stories

Opportunity We need more cutting-edge medical breakthroughs to produce medical devices and treatments that can improve health outcomes for everyone.

Opportunity Surgeons all over the world face the challenge of tediously hand-sewing micro arteries to re-establish blood flow to transplanted tissues.

Who are Kitea Health?

Who are Alimetry?

Who are Wellumio?

At a glance Previously focussed on animal probiotics, a meeting with Callaghan Innovation at Fieldays® opened the way for BioBrew to move into human health supplements.

At a glance Saflex Pumps had already developed chemical dispensing equipment for the dairy industry.

At a glance Biotech startup Amaroq Therapeutics is developing therapies to fight some of the most hard-to-treat and prevalent cancers.

At a glance Helico is aiming to produce therapeutic compounds from plants and, ultimately, ‘edible medicine’, with the technology potentially increasing accessibility and affordability of essential medicines.

At a glance After being granted New Zealand’s first GMP licence, Helius Therapeutics got the green light to manufacture medical cannabis products in a bid to bring the first locally-made products to market.

Callaghan Innovation has launched a HealthTech Activator (HTA) to support commercialisation in New Zealand’s healthtech sector, which generated an estimated $2.85 billion revenue last financial year, with many healthtech companies achieving record growth since COVID-19 struck.

At a glance With a growing resistance to antibiotics for infections, Manuka Bioscience has been exploring using oil from East Cape mānuka trees to develop treatments for skin infections.